As I said in an earlier post I was not expecting anything

New Post Public Reply Private Reply Replies (2) Message Board
BruceLake GaryM #10408
934
As I said in an earlier post I was not expecting anything that we didn't already know. But a few things were nevertheless reassuring.

For example:
Good to know that they have not squandered the money they raised.
Quote:
On June 30, 2017, we had current assets of $1,402,208 consisting of $1,379,895 in cash and other current assets of $22,313.


Besides confirming the company's action against the NYC law firm of Sichenzia Ross Ference Kesner LLP and Marc J. Ross, they also announced the following:
Quote:
On August 10, 2017, the Company filed an action in the Supreme Court of the State of New York, New York County seeking to recover unpaid shares due the company from former employees Ziv Turner, Uri Geller and Dubi Kochvar. The lawsuit also seeks an injunction to restrain the sale of shares of the Company by a transferee, Jeffrey Low, and further seeks to rescind the transfer of shares from Ziv Turner to Jeffrey Low. The action is currently pending and is in the pleading stage.


Does anyone know what National Phase and PCT patents refers to?

Quote:
To date, One World Cannabis has filed 13 National Phase and 3 PCT patents with the United States Patent and Regulatory Office (USPTO), all related to its line of activity related to cannabis-based medical products. Assuming the successful completion of the clinical trials, of which there can be no assurance, the Company believes that it will be able to retain the intellectual rights and secure patent protections.


Let's see if in the near future we get some 8Ks with meat on the bone so that it will propel the stock higher and shut up the naysayers.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading